文献速递湿疹皮炎与荨麻疹

母亲产前补充维生素D与子代出生后4年内特应性湿疹风险:一项随机对照试验的证据

Maternal antenatal vitamin D supplementation and offspring risk of atopic eczema in the first 4 years of life: evidence from a randomized controlled trial.
PubMed 文献 · Br J Dermatol · 2022-08-03

在英国MAVIDOS双盲随机安慰剂对照试验中,孕妇从约14周妊娠至分娩每日服用胆钙化醇1000 IU或匹配安慰剂。调整母乳喂养时长后,子代12月龄时特应性湿疹的OR为0.55(95%CI 0.32-0.97,P=0.04),24月龄和48月龄时效应减弱且无统计学显著性。

要点

  • 产前每日补充胆钙化醇1000 IU与子代12月龄时特应性湿疹风险降低相关(OR 0.55,95%CI 0.32-0.97)。
  • 该保护效应在24月龄(OR 0.76,95%CI 0.47-1.23)和48月龄(OR 0.75,95%CI 0.37-1.52)未达统计学显著。
  • 分层显示母乳喂养≥1个月婴儿中干预组湿疹风险降低(OR 0.48,95%CI 0.24-0.94),<1个月者无显著差异(OR 0.80,95%CI 0.29-2.17)。

核心结论

  • 产前补充胆钙化醇对婴儿期特应性湿疹风险具有保护作用的首次随机对照试验证据,效应可能通过增加母乳胆钙化醇水平实现。
  • 研究结果支持特应性湿疹的发育性影响,并提示围产期可能存在可改变的影响因素。

研究设计与样本

  • 英国MAVIDOS双盲随机安慰剂对照试验,孕妇从约14周妊娠至分娩每日服用胆钙化醇1000 IU或匹配安慰剂。
  • 子代特应性湿疹患病率依据英国工作组特应性皮炎定义标准,在12月龄(n=635)、24月龄(n=610)和48月龄(n=449)时确定。
  • 试验注册号:ISRCTN 82927713,EudraCT 2007-001716-23。

主要发现

  • 调整母乳喂养时长后,接受胆钙化醇1000 IU/日的母亲子代12月龄时特应性湿疹OR为0.55(95%CI 0.32-0.97,P=0.04)。
  • 24月龄时OR为0.76(95%CI 0.47-1.23),48月龄时OR为0.75(95%CI 0.37-1.52),效应减弱且无统计学显著性。
  • 干预与母乳喂养时长在12月龄湿疹上的统计交互作用不显著(P=0.41)。
  • 分层显示母乳喂养≥1个月的婴儿中干预组湿疹风险降低(OR 0.48,95%CI 0.24-0.94,P=0.03),母乳喂养<1个月者无显著差异(OR 0.80,95%CI 0.29-2.17,P=0.66)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence linking prenatal maternal vitamin D supplementation with the offspring's risk of atopic eczema is inconsistent, with most data coming from observational studies. OBJECTIVES: To examine the influence of maternal cholecalciferol supplementation during pregnancy on the risk of atopic eczema in the offspring at ages 12, 24 and 48 months. METHODS: Within the UK Maternal Vitamin D Osteoporosis Study (MAVIDOS) double-blind, randomized placebo-controlled trial, we examined the relationship of maternal vitamin D supplementation during pregnancy with offspring atopic eczema at ages 12, 24 and 48 months. In MAVIDOS, pregnant women were allocated to either cholecalciferol 1000 IU per day or matched placebo, taken from around 14 weeks' gestation until delivery, with the primary outcome of neonatal whole-body bone mineral content. The prevalence of atopic eczema in the offspring was ascertained at ages 12 (n = 635), 24 (n = 610) and 48 (n = 449) months, based on the UK Working Party criteria for the definition of atopic dermatitis. The trial was registered with ISRCTN (82927713) and EudraCT (2007-001716-23). RESULTS: The characteristics of mothers and offspring were similar between the intervention and placebo groups, apart from longer breastfeeding duration in the intervention group. Adjusting for breastfeeding duration, offspring of mothers who received cholecalciferol 1000 IU daily had a lower odds ratio (OR) of atopic eczema at age 12 months [OR 0·55, 95% confidence interval (CI) 0·32-0·97, P = 0·04]; this effect weakened and was not statistically significant at ages 24 months (OR 0·76, 95% CI 0·47-1·23) or 48 months (OR 0·75, 95% CI 0·37-1·52). The statistical interaction of intervention and breastfeeding duration in relation to eczema at age 12 months was not significant (P = 0·41), but stratification showed reduced infantile eczema risk in the intervention group for infants breastfed for ≥ 1 month (OR 0·48, 95% CI 0·24-0·94, P = 0·03) but not in those breastfed for < 1 month (OR 0·80, 95% CI 0·29-2·17, P = 0·66). CONCLUSIONS: Our data provide the first randomized controlled trial evidence of a protective effect of antenatal cholecalciferol supplementation on the risk of infantile atopic eczema, with the effect potentially being via increased breast milk cholecalciferol levels. The findings support a developmental influence on atopic eczema, and point to a potentially modifiable perinatal influence on atopic eczema. What is already known about this topic? There are currently no antenatal interventions proven to reduce the incidence of infantile atopic eczema in the general population. However, observational studies have led to speculation that antenatal vitamin D supplementation may be beneficial.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. El-Heis S, D'Angelo S, Curtis EM, et al. Maternal antenatal vitamin D supplementation and offspring risk of atopic eczema in the first 4 years of life: evidence from a randomized controlled trial. Br J Dermatol. 2022. PMID: 35763390. doi:10.1111/bjd.21721

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。